본문 바로가기
KERD
논문KCI 등재

Idiopathic Noncirrhotic Portal Hypertension: An Appraisal

이화정|Aseeb Ur Rehman|M. Isabel Fiel
대한병리학회|2016.01|Journal of Pathology and Translational Medicine|제50권 제1호|pp. 17-25|DOI http://dx.doi.org/10.4132/jptm.2015.09.23

1

조회

0

다운로드

1

인용

0

참고문헌

키워드

HypertensionportalLiverIdiopathicHistopathologyNoncirrhotic
주제분류병리학

초록

Idiopathic noncirrhotic portal hypertension is a poorly defined clinical condition of unknown etiology. Patients present with signs and symptoms of portal hypertension without evidence of cirrhosis. The disease course appears to be indolent and benign with an overall better outcome than cirrhosis, as long as the complications of portal hypertension are properly managed. This condition has been recognized in different parts of the world in diverse ethnic groups with variable risk factors, resulting in numerous terminologies and lack of standardized diagnostic criteria. Therefore, although the diagnosis of idiopathic noncirrhotic portal hypertension requires clinical exclusion of other conditions that can cause portal hypertension and histopathologic confirmation, this entity is under-recognized clinically as well as pathologically. Recent studies have demonstrated that variable histopathologic entities with different terms likely represent a histologic spectrum of a single entity of which obliterative portal venopathy might be an underlying pathogenesis. This perception calls for standardization of the nomenclature and formulation of widely accepted diagnostic criteria, which will facilitate easier recognition of this disorder and will highlight awareness of this entity.

Abstract

Idiopathic noncirrhotic portal hypertension is a poorly defined clinical condition of unknown etiology. Patients present with signs and symptoms of portal hypertension without evidence of cirrhosis. The disease course appears to be indolent and benign with an overall better outcome than cirrhosis, as long as the complications of portal hypertension are properly managed. This condition has been recognized in different parts of the world in diverse ethnic groups with variable risk factors, resulting in numerous terminologies and lack of standardized diagnostic criteria. Therefore, although the diagnosis of idiopathic noncirrhotic portal hypertension requires clinical exclusion of other conditions that can cause portal hypertension and histopathologic confirmation, this entity is under-recognized clinically as well as pathologically. Recent studies have demonstrated that variable histopathologic entities with different terms likely represent a histologic spectrum of a single entity of which obliterative portal venopathy might be an underlying pathogenesis. This perception calls for standardization of the nomenclature and formulation of widely accepted diagnostic criteria, which will facilitate easier recognition of this disorder and will highlight awareness of this entity.

참고문헌 (85)

  1. Berzigotti A, "Assessing portal hypertension in liver diseases", Expert Rev Gastroenterol Hepatol, 7, pp.141~155 (2013)
  2. Rajekar H, "Noncirrhotic portal hypertension", J Clin Exp Hepatol, 1, pp.94~108 (2011)
  3. Schouten JN, "Idiopathic non-cirrhotic portal hypertension:a review", Orphanet J Rare Dis, 10, pp.67~ (2015)
  4. Nakanuma Y, "Histopathology of the liver in non-cirrhotic portal hypertension of unknown aetiology", Histopathology, 28, pp.195~204 (1996)
  5. Sciot R, "Incomplete septal cirrhosis:histopathological aspects", Histopathology, 13, pp.593~603 (1988)
  6. Hillaire S, "Idiopathic non-cirrhotic intrahepatic portal hypertension in the West: a re-evaluation in 28patients", Gut, 51, pp.275~280 (2002)
  7. Wanless IR, "Nodular regenerative hyperplasia of the liver in hematologic disorders: a possible response to obliterative portal venopathy. A morphometric study of nine cases with an hypothesis on the pathogenesis", Medicine (Baltimore), 59, pp.367~379 (1980)
  8. Schouten JN, "Idiopathic noncirrhotic portal hypertension", Hepatology, 54, pp.1071~1081 (2011)
  9. Sarin SK, "Noncirrhotic portal fibrosis", idiopathic portal hypertension: APASL recommendations for diagnosis and treatment, 2007, pp.1, 398~413
  10. Siramolpiwat S, "Idiopathic portal hypertension:natural history and long-term outcome", Hepatology, 59, pp.2276~2285 (2014)
  11. Lee H, "Histological spectrum of idiopathic noncirrhotic portal hypertension in liver biopsies from dialysis patients", Int J Surg Pathol, 23, pp.439~446 (2015)
  12. Krasinskas AM, "Liver transplantation for severe intrahepatic noncirrhotic portal hypertension", Liver Transpl, 11, pp.627~634 (2005)
  13. Banti G, "Splenomegalie mit Leberzirrhose", Beitr Pathol Anat, 24, pp.21~33 (1889)
  14. Okudaira M, "Idiopathic portal hypertension and its pathology", Semin Liver Dis, 22, pp.59~72 (2002)
  15. Lubitz JM, "Banti’s syndrome with multiple aneurysms and thromboses of the splenic blood vessels", Ann Intern Med, 26, pp.594~599 (1947)
  16. McMichael J, "The pathology of hepatolienal fibrosis", J Pathol Bacteriol, 39, pp.481~502 (1934)
  17. Rousselot LM, "The role of congestion (portal hypertension) in socalled Banti’s syndrome: a clinical and pathologic study of thirtyone cases with the late results following splenectomy", JAMA, 107, pp.1788~1793 (1936)
  18. Whipple AO, "The problem of portal hypertension in relation to the hepatosplenopathies", Ann Surg, 122, pp.449~475 (1945)
  19. Mikkelsen WP, "Extra- and intrahepatic portal hypertension without cirrhosis (hepatoportal sclerosis)", Ann Surg, 162, pp.602~620 (1965)
  20. Boyer JL, "Idiopathic portal hypertension : comparison with the portal hypertension of cirrhosis and extrahepatic portal vein obstruction", Ann Intern Med, 66, pp.41~68 (1967)
  21. Nayak NC, "Obliterative portal venopathy of the liver: associated with so-called idiopathic portal hypertension or tropical splenomegaly", Arch Pathol, 87, pp.359~369 (1969)
  22. Epidemiology of idiopathic portal hypertension based on a nation-wide survey. Report of the Ministry of Health and Welfare Research Committee on Idiopathic Portal Hypertension, "Kobayashi Y", Japan Ministry of Health and Welfare, 10~15 (1976)
  23. Levison DA, "Slow cirrhosis:or no cirrhosis? A lesion causing benign intrahepatic portal hypertension", J Pathol, 137, pp.253~272 (1982)
  24. Polish E, "Idiopathic presinusoidal portal hypertension (Banti’s syndrome)", Ann Intern Med, 56, pp.624~627 (1962)
  25. Ranstrom S, "Miliary hepatocellular adenomatosis", Acta Pathol Microbiol Scand, 33, pp.225~229 (1953)
  26. Steiner PE, "Nodular regenerative hyperplasia of the liver", J Pathol, 35, pp.943~953 (1959)
  27. Wanless IR, "Micronodular transformation (nodular regenerative hyperplasia) of the liver: a report of 64 cases among 2,500 autopsies and a new classification of benign hepatocellular nodules", Hepatology, 11, pp.787~797 (1990)
  28. Popper H, "Controversy in internal medicine", pp.233~243 (1966), W.B. Saunders
  29. Wanless IR, "Regression of human cirrhosis:morphologic features and the genesis of incomplete septal cirrhosis", Arch Pathol Lab Med, 124, pp.1599~1607 (2000)
  30. Sherlock S, "Partial nodular transformation of the liver with portal hypertension", Am J Med, 40, pp.195~203 (1966)
  31. Wanless IR, "Partial nodular transformation of liver in an adult with persistent ductus venosus: review with hypothesis on pathogenesis", Arch Pathol Lab Med, 109, pp.427~432 (1985)
  32. Aggarwal S, "Obliterative portal venopathy : a clinical and histopathological review", Dig Dis Sci, 58, pp.2767~2776 (2013)
  33. Hallenbeck GA, "Esophagogastric varices without hepatic cirrhosis: a clinical study of treatment for their bleeding in 72cases", Arch Surg, 83, pp.370~383 (1961)
  34. Okuda K, "Liver pathology of idiopathic portal hypertension: comparison with non-cirrhotic portal fibrosis of India. The Japan idiopathic portal hypertension study", Liver, 2, pp.176~192 (1982)
  35. Iber FL, "Obliterative portal venopathy of the liver and “idiopathic portal hypertension”", Ann Intern Med, 71, pp.660~661 (1969)
  36. Sarin SK, "Non-cirrhotic portal fibrosis", J Gastroenterol Hepatol, 17(Suppl 3), pp.S214~S223 (2002)
  37. Villeneuve JP, "Idiopathic portal hypertension", Am J Med, 61, pp.459~464 (1976)
  38. Kingham JG, "Non-cirrhotic intrahepatic portal hypertension: a long term follow-up study", Q J Med, 50, pp.259~268 (1981)
  39. Eapen CE, "Non-cirrhotic intrahepatic portal hypertension: associated gut diseases and prognostic factors", Dig Dis Sci, 56, pp.227~235 (2011)
  40. Okuda K, "Non-cirrhotic portal hypertension versus idiopathic portal hypertension", J Gastroenterol Hepatol, 17(Suppl 3), pp.S204~S213 (2002)
  41. Moran CA, "Nodular regenerative hyperplasia of the liver in children", Am J Surg Pathol, 15, pp.449~454 (1991)
  42. Kochin I, "Variceal bleeding in an adolescent with HIV diagnosed with hepatoportal sclerosis and nodular regenerative hyperplasia", J Pediatr Gastroenterol Nutr, 50, pp.340~343 (2010)
  43. Tinsa F, "Nodular regenerative hyperplasia of the liver, celiac disease and Sjogren’s syndrome in a child", Gastroenterol Clin Biol, 34, pp.40~42 (2010)
  44. Yilmaz G, "Hepatoportal sclerosis in childhood: some presenting with cholestatic features (a reevaluation of 12 children)", Pediatr Dev Pathol, 15, pp.107~113 (2012)
  45. Franchi-Abella S, "Obliterative portal venopathy:a study of 48 children", J Pediatr, 165, pp.190~193 (2014)
  46. Cazals-Hatem D, "Obliterative portal venopathy:portal hypertension is not always present at diagnosis", J Hepatol, 54, pp.455~461 (2011)
  47. Tsuneyama K, "Overlap of idiopathic portal hypertension and scleroderma: report of two autopsy cases and a review of literature", J Gastroenterol Hepatol, 17, pp.217~223 (2002)
  48. Austin A, "Nodular regenerative hyperplasia of the liver and coeliac disease: potential role of IgA anticardiolipin antibody", Gut, 53, pp.1032~1034 (2004)
  49. Agrawal M, "Hepatoportal sclerosis (obliterative portal venopathy) and nodular regenerative hyperplasia in a patient with myasthenia gravis: a case report and review of the published work", Hepatol Res, 43, pp.999~1003 (2013)
  50. Mori K, "Idiopathic portal hypertension associated with high serum titer of autoantibodies and liver dysfunction", J Gastroenterol, 31, pp.123~128 (1996)
  51. Saito K, "Non-specific immunological abnormalities and association of autoimmune diseases in idiopathic portal hypertension: a study by questionnaire", Hepatogastroenterology, 40, pp.163~166 (1993)
  52. Kogawa H, "Idiopathic portal hypertension associated with systemic sclerosis and Sjogren’s syndrome", Clin Rheumatol, 24, pp.544~547 (2005)
  53. Leung VK, "Nodular regenerative hyperplasia of the liver associated with systemic lupus erythematosus: three cases", Hong Kong Med J, 15, pp.139~142 (2009)
  54. Park YW, "Association of nodular regenerative hyperplasia of the liver with porto-pulmonary hypertension in a patient with systemic lupus erythematosus", Lupus, 15, pp.686~688 (2006)
  55. Malamut G, "Nodular regenerative hyperplasia:the main liver disease in patients with primary hypogammaglobulinemia and hepatic abnormalities", J Hepatol, 48, pp.74~82 (2008)
  56. Nakanuma Y, "Pathology of the liver in “idiopathic portal hypertension” associated with autoimmune disease. The Ministry of Health and Welfare Disorders of Portal Circulation Research Committee", Acta Pathol Jpn, 39, pp.586~592 (1989)
  57. Dash SC, "Increased incidence of glomerulonephritis following spleno-renal shunt surgery in non-cirrhotic portal fibrosis", Kidney Int, 52, pp.482~485 (1997)
  58. Sarin SK, "Non-cirrhotic portal fibrosis : current concepts and management", J Gastroenterol Hepatol, 17, pp.526~534 (2002)
  59. Sarin SK, "Non-cirrhotic portal hypertension", Clin Liver Dis, 18, pp.451~476 (2014)
  60. Kovari H, "Association of noncirrhotic portal hypertension in HIV-infected persons and antiretroviral therapy with didanosine: a nested case-control study", Clin Infect Dis, 49, pp.626~635 (2009)
  61. Schiano TD, "The development of hepatoportal sclerosis and portal hypertension due to didanosine use in HIV", Virchows Arch, 458, pp.231~235 (2011)
  62. Vispo E, "Genetic determinants of idiopathic noncirrhotic portal hypertension in HIV-infected patients", Clin Infect Dis, 56, pp.1117~1122 (2013)
  63. Scoazec JY, "Peliosis hepatis and sinusoidal dilation during infection by the human immunodeficiency virus (HIV): an ultrastructural study", Am J Pathol, 131, pp.38~47 (1988)
  64. Vakili C, ""Endemic"idiopathic portal hypertension : report on 32 patients with non-cirrhotic portal fibrosis", World J Surg, 16, pp.118~124 (1992)
  65. Barnard JA, "Noncirrhotic portal fibrosis after Wilms’ tumor therapy", Gastroenterology, 90, pp.1054~1056 (1986)
  66. Verheij J, "Histological features in western patients with idiopathic non-cirrhotic portal hypertension", Histopathology, 62, pp.1083~1091 (2013)
  67. Girard M, "Adams-Oliver syndrome and hepatoportal sclerosis: occasional association or common mechanism?", Am J Med Genet A, 135, pp.186~189 (2005)
  68. Roulot D, "Liver involvement in Turner syndrome", Liver Int, 33, pp.24~30 (2013)
  69. de Lonlay P, "The clinical spectrum of phosphomannose isomerase deficiency, with an evaluation of mannose treatment for CDG-Ib", Biochim Biophys Acta, 1792, pp.841~843 (2009)
  70. Albuquerque A, "Familial occurrence of nodular regenerative hyperplasia of the liver", Am J Gastroenterol, 108, pp.150~151 (2013)
  71. Dumortier J, "Familial occurrence of nodular regenerative hyperplasia of the liver: a report on three families", Gut, 45, pp.289~294 (1999)
  72. Sarin SK, "Familial aggregation in noncirrhotic portal fibrosis: a report of four families", Am J Gastroenterol, 82, pp.1130~1133 (1987)
  73. Köksal AS, "Clinical features, serum interleukin-6, and interferon-gamma levels of 34 turkish patients with hepatoportal sclerosis", Dig Dis Sci, 52, pp.3493~3498 (2007)
  74. Mallet VO, "Acquired protein S deficiency leads to obliterative portal venopathy and to compensatory nodular regenerative hyperplasia in HIV-infected patients", AIDS, 23, pp.1511~1518 (2009)
  75. Tublin ME, "Altered liver morphology after portal vein thrombosis: not always cirrhosis", Dig Dis Sci, 53, pp.2784~2788 (2008)
  76. Seijo S, "Role of hepatic vein catheterisation and transient elastography in the diagnosis of idiopathic portal hypertension", Dig Liver Dis, 44, pp.855~860 (2012)
  77. Chawla Y, "Anorectal varices: their frequency in cirrhotic and non-cirrhotic portal hypertension", Gut, 32, pp.309~311 (1991)
  78. Dhiman RK, "Non-cirrhotic portal fibrosis (idiopathic portal hypertension): experience with 151 patients and a review of the literature", J Gastroenterol Hepatol, 17, pp.6~16 (2002)
  79. Isabel Fiel M, "Liver failure and need for liver transplantation in patients with advanced hepatoportal sclerosis", Am J Surg Pathol, 31, pp.607~614 (2007)
  80. Ludwig J, "Idiopathic portal hypertension:a histopathological study of 26 Japanese cases", Histopathology, 22, pp.227~234 (1993)
  81. Krishnan P, "Hepatoportal sclerosis:CT and MRI appearance with histopathologic correlation", AJR Am J Roentgenol, 198, pp.370~376 (2012)
  82. Furuichi Y, "Noninvasive diagnostic method for idiopathic portal hypertension based on measurements of liver and spleen stiffness by ARFI elastography", J Gastroenterol, 48, pp.1061~1068 (2013)
  83. Kage M, "Pathomorphologic study on the extrahepatic portal vein in idiopathic portal hypertension", Liver, 10, pp.209~216 (1990)
  84. Garcia-Tsao G, "Practice Guidelines Committee of American Association for Study of Liver Diseases;Practice Parameters Committee of American College of Gastroenterology. Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis", Am J Gastroenterol, 102, pp.2086~2102 (2007)
  85. Bihl F, "Anticoagulant therapy for nodular regenerative hyperplasia in a HIV-infected patient", BMC Gastroenterol, 10, pp.6~ (2010)

관련 논문AI추천

Recent Advances in the Pathogenesis and Clinical Evaluation of Portal Hypertension in Chronic Liver DiseaseKawada Norifumi, Kotani Kohei거트앤리버 소화기연관학회협의회 · Gut and Liver2024 · 제18권 제1호Non-cirrhotic portal hypertension in an ankylosing spondylitis patient김상현, 김현우, 박석기, 심범진, 이지현, 최원규, 최준설영남대학교 의과대학 · Journal of Yeungnam Medical Science2018 · 제35권 제1호특발성 문맥압 항진증 8예의 임상 및 병리학적 분석김경모, 김경은, 유은실, 임영석대한병리학회 · Journal of Pathology and Translational Medicine2006 · 제40권 제5호Ultrasonography for Noninvasive Assessment of Portal HypertensionHitoshi Maruyama, Osamu Yokosuka거트앤리버 소화기연관학회협의회 · Gut and Liver2017 · 제11권 제4호Portosystemic collateral pathways and interventions in portal hypertensionAnirudh Mirakhur, Murad Feroz Bandali소화기인터벤션의학회 · International Journal of Gastrointestinal Intervention2018 · 제7권 제1호Precirrhotic Primary Biliary Cholangitis with Portal Hypertension: Bile Duct Injury CorrelateChen Miao-Yang, Du Zhi-Xiang, Hu Yi-Fan, Li Shun-Xin, Liu Du-Xian, Liu Hong-Li, Wang Li, Wang Shuang-Shuang, Xiong Qing-Fang, Yang Yong-Feng, Zhong Yan-Dan거트앤리버 소화기연관학회협의회 · Gut and Liver2024 · 제18권 제5호

이 간행물의 다른 논문 (11건)

Molecular Dimensions of Gastric Cancer: Translational and Clinical Perspectives정재호, 노성훈, 최윤영pp. 1-9Ménétrier’s Disease: Its Mimickers and PathogenesisWon Jae Huh, Mary Kay Washington, Robert J. Coffeypp. 10-16Overview of IgG4-Related Tubulointerstitial Nephritis and Its Mimickers임범진, 정현주, 신수진pp. 26-36Review of Medical Advisory Services by the Korean Society of Pathologists from 2003 to 2014Min Hye Jang, 김완섭, 이건국, 김한성pp. 37-44Eosinophils in Colorectal Neoplasms Associated with Expression of CCL11 and CCL24원규연, 임성직, Hyuck Cho, 민지원, 김교영, 배고은, 노병주pp. 45-51
원문 보기